# OnCo record idea-bio2-nk-cells-for-mrd (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-bio2-nk-cells-for-mrd/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-bio2-nk-cells-for-mrd" ;
  schema:name "Off-the-shelf natural killer cells to sweep up residual disease"@en ;
  schema:description "Donor immune cells that need no matching could be given as short courses to clear the few cancer cells left after surgery, when the target is smallest."@en ;
  schema:url <https://onco.cc/ideas/idea-bio2-nk-cells-for-mrd/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2200075> ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/car-nk-macrophage/>, <https://onco.cc/technologies/allogeneic-cell-therapy/>, <https://onco.cc/technologies/mrd-testing/> ;
  onco:drugs <https://onco.cc/drugs/nogapendekin-alfa/> ;
  onco:companies <https://onco.cc/companies/nkarta/>, <https://onco.cc/companies/fate-therapeutics/>, <https://onco.cc/companies/immunitybio/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/crs/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-dormancy-mrd/>, <https://onco.cc/bottlenecks/b-manufacturing-cell-therapy/> .
